Perspectives of contained chondroprotective therapy of osteoarthritis. Results of an open randomized study of Artra preparation in patients with gonarthrosis
https://doi.org/10.14412/1995-4484-2004-808
Abstract
References
1. <div><p>Brandt K.D., Doherty M.,.Lohmander L. S. Osteoarthritis, OXFORD university press, second edition, 2003,1-7, 74-99</p><p>Jordan K.M.,. Arden, Doherty M. et al. EULAR Reccomendations 2003: an evidence based approach to the management of osteoarthritis: Report of a task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT), Ann. Rheum. Dis., 2003, 1, 1-13</p><p>Lippielo L., Woodword J., Karpman D. Et al. Beneficial effect of cartilage structure modifying agents tested in chon drocyte and rabbit instability model osteoartroses. Arthr. Rheum., 1999, suppl. 42, 256</p><p>Leffler C.N., Phillipi A.F., Leffler S.G. et al. Glucosamine, chondroitin and magnaese ascorbate for degenerative joint disease of the knee or low back pain: a randomized, double-blind, placebo-controlled pilot study. Mil. Med., 1999, 164, 85-91</p><p>Grosh P. et a. Second-line agents in the treatment of rheumatic disease, J.S. Dixon, D.E. Furst, Eds., Marcel Dekker, New York. 1992, 363-427</p></div><br />
Review
For citations:
Alexeeeva L.L., Chichasova N.V., Benevolenskaya L., Mendel O.L., Nassonov E.L. Perspectives of contained chondroprotective therapy of osteoarthritis. Results of an open randomized study of Artra preparation in patients with gonarthrosis. Rheumatology Science and Practice. 2004;42(4):77-79. (In Russ.) https://doi.org/10.14412/1995-4484-2004-808